Tracking Kahn Brothers' Portfolio- Seeking Alpha
This article is part of a series that provides an ongoing analysis of the changes made to Kahn Brothers' 13F stock portfolio on a quarterly basis. It is based on Kahn Brothers' regulatory 13F Form filed on 11/05/2019. Please visit our Tracking Kahn Brothers Portfolio series to get an idea of its investment philosophy and our last update for the fund's moves during Q2 2019.
This quarter, Kahn Brothers' 13F portfolio value decreased marginally from $800M to $798M. The number of holdings increased from 44 to 48. The largest individual stock position is Merck (NYSE:MRK) which accounts for 11.30% of the portfolio. Largest five positions are Merck Inc., Citigroup Inc. (NYSE:C), Assured Guaranty (NYSE:AGO), New York Community Bancorp (NYSE:NYCB), and GlaxoSmithKline plc (NYSE:GSK). Together, th ...